Search
for
Sort by
Research 721–750 of 1000+
- Male Androgenetic Alopecia — Endotext
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Advances in Nanotechnology Research in Food Production, Nutrition, and Health
- Ottawa, Ontario, Canada, February 13–16, 2013
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- TELECONSULTA EM INSUFICIÊNCIA CARDÍACA: REVISÃO DE ESCOPO
- PMON281 PERSISTENT VIRILIZATION AND VASOMOTOR SYMPTOMS IN A TRANSMAN 5-YEARS POST TESTOSTERONE WITHDRAWAL
- Clinical aspects of the metabolic syndrome
- Abstracts of 42nd National Conference of Association of Clinical Biochemists of India (ACBICON 2015)
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Pramipexole
- Metformin effects on Polycystic Ovarian Syndrome
- Androgen Treatment in Women
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Severe Acute Respiratory Syndrome (SARS)
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- A retrospective case-control study of modifiable risk factors and cutaneous markers in Indian patients with young coronary artery disease
- Impact of lisinopril on cardiometabolic risk factors in men with hypertension and early-onset androgenetic alopecia
- Pericardial Disorders Occurring During Open-Label Study of 1,869 Severely Hypertensive Patients Treated with Minoxidil
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Male-pattern baldness and incident coronary heart disease and risk factors in the Heinz Nixdorf Recall Study
- Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors
- Hair Loss, Insulin Resistance, and Heredity in Middle-aged Women. a Population-based Study
- The risk of coronary heart disease in men with androgenetic alopecia
- Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink